We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
RemedyMD Announces Investigate Cell Therapy, a Research Management System
News

RemedyMD Announces Investigate Cell Therapy, a Research Management System

RemedyMD Announces Investigate Cell Therapy, a Research Management System
News

RemedyMD Announces Investigate Cell Therapy, a Research Management System

Read time:
 

Want a FREE PDF version of This News Story?

Complete the form below and we will email you a PDF version of "RemedyMD Announces Investigate Cell Therapy, a Research Management System"

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

RemedyMD, the leading provider of Translational Research Informatics, will launch Investigate(TM) Cell Therapy at the American Society for Blood and Marrow Transplantation BMT Tandem Meetings Feb. 1 - Feb. 5 in San Diego, Calif. (Booth #604).

"Investigate Cell Therapy is designed to improve research efficiencies, facilitate pattern recognition and accelerate discoveries in BMT centers," said Hank Wu, Investigate product manager for RemedyMD.

Fully integrated with ComprehensiveBMT(TM), Investigate Cell Therapy is the world's only blood and marrow research management system capable of integrating next-generation sequencing, cross-disease registries, and long-term complications and outcomes to advance cell therapy research.

Researchers benefit from:

-    Aggregation of disparate data types from bench to bedside data sources with an intelligent ontology that harmonizes biospecimen, registry and outcomes data
-    360-degree perspective of phenotypic and genotypic data for subjects, patients, diseases
-    Configurability that keeps up with the pace of research, without waiting for software coding or database administration
-    Multisite, real-time research collaboration without the cost and complexity of infrastructure building and maintenance
-    A suite of reporting, analysis, and data visualization tools that enable drag-and-drop reporting by researchers, scientists, and clinicians without writing SQL

Investigate Cell Therapy leverages the same research platform implemented at the Blood Research Institute of the Blood Center of Wisconsin to integrate lab information management systems (LIMS), study design and tracking, patient registries, and data mining and visualization.

"Research is fundamentally an exercise in pattern recognition," said Gary Kennedy, Founder and CEO of RemedyMD. "Bringing the power of Investigate(TM) to bear on cell therapy research will provide blood and marrow researchers with the technology they need to recognize new patterns and increase the speed of discovery."

RemedyMD will demonstrate Investigate Cell Therapy at BOOTH #604 at the 2012 Tandem Meetings in San Diego, Calif. beginning Feb. 1 - Feb. 5.

Advertisement